Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Coukos

Showing results (271-280 of 355) with videos related to

Pageof 36
Sort By:
Nature Medicine|August 31, 2004
Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-AJose R Conejo-Garcia, Fabian Benencia, Maria-Cecilia Courreges, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 19, 2024
Predicting Antigen-Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDistMarta A S Perez, Johanna Chiffelle, Sara Bobisse, et al.
Journal of Translational Medicine|November 28, 2019
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinomaApostolos Sarivalasis, Caroline Boudousquié, Klara Balint, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2020
Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancerBeatris Mastelic-Gavillet, Apostolos Sarivalasis, Leyder Elena Lozano, et al.
Oncoimmunology|September 22, 2017
Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapyAndrea Facciabene, Francesco De Sanctis, Stefano Pierini, et al.
Cancer Biology & Therapy|July 26, 2011
Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinomaAndrea R Hagemann, Ian S Hagemann, Mark Cadungog, et al.
Nature Cell Biology|January 15, 2008
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasisQihong Huang, Kiranmai Gumireddy, Mariette Schrier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2019
High-throughput Screening of Human Tumor Antigen-specific CD4 T Cells, Including Neoantigen-reactive T CellsCarla Costa-Nunes, Amélie Cachot, Sara Bobisse, et al.
Oncoimmunology|April 9, 2016
TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancerSylvian Bron, Luc Henry, Eveline Faes-Van't Hull, et al.
Cancer Research|February 12, 2005
Transcriptional coactivator Drosophila eyes absent homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growthLin Zhang, Nuo Yang, Jia Huang, et al.
Pageof 36

Showing results (271-280 of 355) with videos related to

Sort By:
Pageof 36
Nature Medicine|August 31, 2004
Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-AJose R Conejo-Garcia, Fabian Benencia, Maria-Cecilia Courreges, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 19, 2024
Predicting Antigen-Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDistMarta A S Perez, Johanna Chiffelle, Sara Bobisse, et al.
Journal of Translational Medicine|November 28, 2019
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinomaApostolos Sarivalasis, Caroline Boudousquié, Klara Balint, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2020
Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancerBeatris Mastelic-Gavillet, Apostolos Sarivalasis, Leyder Elena Lozano, et al.
Oncoimmunology|September 22, 2017
Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapyAndrea Facciabene, Francesco De Sanctis, Stefano Pierini, et al.
Cancer Biology & Therapy|July 26, 2011
Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinomaAndrea R Hagemann, Ian S Hagemann, Mark Cadungog, et al.
Nature Cell Biology|January 15, 2008
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasisQihong Huang, Kiranmai Gumireddy, Mariette Schrier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2019
High-throughput Screening of Human Tumor Antigen-specific CD4 T Cells, Including Neoantigen-reactive T CellsCarla Costa-Nunes, Amélie Cachot, Sara Bobisse, et al.
Oncoimmunology|April 9, 2016
TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancerSylvian Bron, Luc Henry, Eveline Faes-Van't Hull, et al.
Cancer Research|February 12, 2005
Transcriptional coactivator Drosophila eyes absent homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growthLin Zhang, Nuo Yang, Jia Huang, et al.
Pageof 36